ANNUAL RESULTS
Sun Pharmaceutical Industries Ltd.
BSE
Jun 27
1688.00
+18.70 (+ 1.12%)
Volume
80542
Prev. Close
1669.30
Open Price
1668.05
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 27
1687.60
+17.80 (+ 1.07%)
Volume
5313904
Prev. Close
1669.80
Open Price
1670.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
ISIN No
|
INE044A01036
|
Market Cap. ( ₹ in Cr. )
|
404911.77
|
P/BV
|
5.86
|
Book Value ( ₹ )
|
288.06
|
BSE Code
|
524715
|
52 Week High/Low ( ₹ )
|
1960/1498
|
FV/ML
|
1/1
|
P/E(X)
|
37.05
|
NSE Code
|
SUNPHARMAEQ
|
Book Closure
|
07/07/2025
|
EPS ( ₹ )
|
45.55
|
Div Yield (%)
|
0.95
|
(₹ in Crs.)
Net Sales/Income from operations | 22625.88 | 20275.17 | 20394.63 | 15518.50 | 12570.93 |
Other Operating Income | 377.45 | 0.00 | 417.51 | 67.48 | 232.28 |
Total Income From Operations | 23003.33 | 20275.17 | 20812.14 | 15585.98 | 12803.21 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 4690.67 | 4429.38 | 5165.63 | 4584.97 | 3809.11 |
Purchase of Traded Goods | 1359.53 | 994.41 | 1126.46 | 1248.60 | 1199.63 |
Increase/Decrease in Stocks | -69.17 | 180.32 | -237.93 | -183.18 | -214.84 |
Employees Cost | 2608.26 | 2373.95 | 2156.95 | 2000.78 | 1798.45 |
Depreciation | 1238.27 | 1600.62 | 1600.87 | 1349.95 | 586.81 |
Other Expenses | 7621.42 | 6709.50 | 6128.17 | 5027.29 | 3274.86 |
Total Expenses | 17448.98 | 16288.18 | 15940.15 | 14028.41 | 10454.02 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 5554.35 | 3986.99 | 4871.99 | 1557.57 | 2349.19 |
Other Income | 369.43 | 465.76 | 279.03 | 957.92 | 150.22 |
P/L Before Interest, Excpt. Items & Tax | 5923.78 | 4452.75 | 5151.02 | 2515.49 | 2499.41 |
Interest | 893.21 | 784.08 | 472.18 | 388.10 | 256.98 |
P/L Before Exceptional Items & Tax | 5030.57 | 3668.67 | 4678.84 | 2127.39 | 2242.43 |
Exceptional Items | 0.00 | -219.02 | -2937.79 | -1820.53 | -89.56 |
P/L Before Tax | 5030.57 | 3449.65 | 1741.05 | 306.86 | 2152.87 |
Tax | 747.95 | 591.47 | 50.33 | 406.85 | 13.17 |
P/L After Tax from Ordinary Activities | 4282.62 | 2858.18 | 1690.72 | -99.99 | 2139.70 |
Net Profit/Loss For the Period | 4282.62 | 2858.18 | 1690.72 | -99.99 | 2139.70 |
| | | | | |
Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
Reserves And Surplus | 24099.92 | 23454.47 | 23508.43 | 24348.02 | 24800.23 |
Equity Dividend Rate | 1600.00 | 1350.00 | 1150.00 | 1000.00 | 750.00 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 |
Diluted EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 |
Diluted EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 |
| | | | | |
PBITOE Margin (%) | 24.14 | 19.66 | 23.40 | 9.99 | 18.34 |
PBTE Margin (%) | 21.86 | 18.09 | 22.48 | 13.64 | 17.51 |
PBT Margin (%) | 21.86 | 17.01 | 8.36 | 1.96 | 16.81 |
PAT Margin (%) | 18.61 | 14.09 | 8.12 | -0.64 | 16.71 |